Cervical cancer is one of the most common neoplastic diseases affecting women, with a
combined worldwide incidence of almost half a million new cases annually, second only to …

Cancer biomarkers: a systems approach | Nature Biotechnology Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …

This ninetieth volume of the IARC Monographs on the Evaluation of Carcinogenic Risks to
Humansconsiders human papillomaviruses (HPVs) which were evaluated by a previous …

Although many phenotypes have been associated with variants in human leukocyte antigen
(HLA) genes, the full phenotypic impact of HLA variants across all diseases is unknown. We …

Genome-wide association studies (GWAS) have successfully identified associations for
cervical cancer, but the underlying mechanisms of cervical biology and pathology remain …

Variation in human major histocompatibility genes may influence the risk of squamous cell
cervical cancer (SCC) by altering the efficiency of the T-cell–mediated immune response to …

PURPOSE: Fetal microchimerism, derived from fetal cells that persist after pregnancy, is
usually evaluated by tests for male microchimerism in women who gave birth to sons. We …

Over 50% of patients with colorectal cancer (CRC) will progress and/or develop metastases.
Biomarkers capable of predicting progression, risk stratification and therapeutic benefit are …

Cervical cancer (CC) is the second most common cancer in women worldwide and the
fourth leading cause of cancer-associated death in women. Although human papillomavirus …

Tumor-infiltrating T cell rescue by programmed cell death receptor-1 (PD-1)/PD-1 ligand-1
(PD-L1) immune checkpoint blockade is a recommended treatment for malignant diseases …